All instruments
Glenmark Pharmaceuticals Limited
- Stock
- GLENMARK
- NSE
- ₹2,590.00+4.36%
- Delayed close, 06 Nov
Details
- INE935A01035
- Healthcare
- Pharmaceuticals
- Face value ₹1
- Market cap ₹73,096 Cr
Paid for 18 years without a break
Dividend per share by FY
Split-adjusted · FY 2026–27 to date · last 7 of 21 years · FY of the ex-date
| Financial year | Total dividend |
|---|---|
| FY 2001–02 | ₹4.00 |
| FY 2006–07 | ₹0.40 |
| FY 2007–08 | ₹0.70 |
| FY 2009–10 | ₹0.40 |
| FY 2010–11 | ₹0.40 |
| FY 2011–12 | ₹0.40 |
| FY 2012–13 | ₹2.00 |
| FY 2013–14 | ₹2.00 |
| FY 2014–15 | ₹2.00 |
| FY 2015–16 | ₹2.00 |
| FY 2016–17 | ₹2.00 |
| FY 2017–18 | ₹2.00 |
| FY 2018–19 | ₹2.00 |
| FY 2019–20 | ₹2.00 |
| FY 2020–21 | ₹2.50 |
| FY 2021–22 | ₹2.50 |
| FY 2022–23 | ₹2.50 |
| FY 2023–24 | ₹2.50 |
| FY 2024–25 | ₹2.50 |
| FY 2025–26 | ₹5.00 |
| FY 2026–27 | ₹2.50 |
TTM payout
₹2.50
1 payout in 12 months
Yield
0.10%
Dividend yield · trailing 12 months
52-wk closing range ₹1,817.30 – ₹2,590.00
Yield and payout totals recalculated 07 Nov 2026.
Recent payouts
· 22 on record since FY 2001–02| Ex-date | Type | Record date | Amount |
|---|---|---|---|
| 31 Aug 2026 | Final | same day | ₹2.50 |
| 03 Oct 2025 | Interim | same day | ₹2.50 |
| 15 Sep 2025 | Final | same day | ₹2.50 |
| 13 Sep 2024 | Final | — | ₹2.50 |
| 18 Sep 2023 | Final | — | ₹2.50 |
Income calculator
₹95
Expected income per year, before tax, at the current 0.10% yield
≈ 38 shares at ₹2,590.00, using ₹98,420 of the ₹1,00,000. Based on the last twelve months’ payouts — not a forecast, and dividends are taxed at your own slab rate.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.